Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 944-449-9 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Skin irritation/corrosion: weight of evidence approach out of two studies (OECD 404 and OECD 439): not irritating
Eye irritation (OECD 437): not irritating
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin corrosion: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 22 Jun - 18 Jul 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- adopted 28 Jul 2015
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- Version / remarks:
- Commission Regulation 440/2008, 1st ATP 2009)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Hess. Ministerium für Umwelt, Klimaschutz, Landwirtschaft und Verbraucherschutz, Wiesbaden, Germany
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Cell source:
- other: EpiDerm™
- Source strain:
- not specified
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EpiDerm™ (EPI-200) (MatTek Corporation, Bratislava, Slovakia)
- Tissue batch number: 23345
- Delivery date: 12 July 2016
- Date of initiation of testing: 12 July 2016
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: 37 ± 1.5 °C for 35 min in the incubator; thereafter at room temperature for 25 min in a sterile bench
REMOVAL OF TEST MATERIAL AND CONTROLS
-Volume and number of washing steps: Tissues were gently rinsed with DPBS at least 15 times in order to remove any residual test material. After the rinsing the inserts were submerged in DPBS at least 3 times. Afterwards the inserts were once again rinsed with DPBS from the inside and the outside.
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 1 mg/mL
- Incubation time: 3 h
- Spectrophotometer: microplate reader (Versamax, Molecular Devices, Softmax Pro v.4.7.1)
- Wavelength: 570 nm
FUNCTIONAL MODEL CONDITIONS WITH REFERENCE TO HISTORICAL DATA
- Viability: The quality of the EpiDerm™ tissue was assessed by undertaking an MTT cell viability test. The determined OD (540 - 570 nm) was 1.783 ± 0.027 (acceptance criteria: 1.0 - 3.0).
- Barrier function: The barrier function was assessed by determination of the exposure time required to reduce tissue viability by 50% (ET-50) upon application of 100 µL of 1% Triton X-100. The ET-50 value was determined to be 6.16 h (acceptance criteria: 4.77-8.72 h).
- Contamination: The cells used to produce the EpiDerm™ tissue were screened for the presence of viruses, bacteria, yeast and other fungi.
NUMBER OF REPLICATE TISSUES: 3
CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE
Since the test substance did not directly reduce MTT, an additional test with freeze-killed tissues was not performed.
NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION: single experiment
PREDICTION MODEL / DECISION CRITERIA
- The test substance is considered to be irritant to skin if the viability after 1 hour exposure is less than 50%. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount applied: 30 µL
NEGATIVE CONTROL
- Amount applied: 30 µL
POSITIVE CONTROL
- Amount applied: 30 µL
- Concentration: 5% aqueous solultion - Duration of treatment / exposure:
- 60 min
- Duration of post-treatment incubation (if applicable):
- approximately 43 h
- Number of replicates:
- triplicates for each treatment and control group
- Irritation / corrosion parameter:
- % tissue viability
- Remarks:
- mean value of 3 tissues
- Run / experiment:
- 60 minutes exposure
- Value:
- 103
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Direct-MTT reduction: The test substance was not considered to be a MTT reducer.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: The negative control OD (1.892, 1.821 and 1.717) were in the range of the required acceptability criterion of mean OD ≥ 0.8 and ≤ 2.8 for the 60 min treatment interval thus showing the quality of the tissues.
- Acceptance criteria met for positive control: Exposure to the positive control induced a decrease in the relative absorbance as compared to the negative control to 2.8% thus confirming the validity of the test system.
- Acceptance criteria met for variability between replicate measurements: The standard deviations of the 3 identical replicates of the test substance, positive and negative control in the main test were below 8% (threshold of OECD 439: <18%), thus ensuring the validity of the study. - Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008
- Conclusions:
- Under the conditions of the reconstructed human epidermis test the test substance does not possess any skin irritating potential.
- Executive summary:
The skin irritation potential of the test substance was determined by an in vitro skin irritation test using a human skin model according to OECD Guideline 439 and in compliance with GLP (2016). After treatment with 30 µL of the test substance the mean relative absorbance value was 103.0% compared to the negative control (threshold for classification <50%).
- Endpoint:
- skin irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 16 Oct - 7 Nov 2000
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 404 (Acute Dermal Irritation / Corrosion)
- Version / remarks:
- adopted Jan 1997
- Deviations:
- yes
- Remarks:
- 5 test substance concenrations were tested in parallel; 4 rabbits instead of 3 rabbits were used
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Ministry of Agriculture, Environmental Protection and Regional Planning, Potsdam, Germany
- Species:
- rabbit
- Strain:
- other: Chbb:HM(SPF) - Littlerussian
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 2.4 - 2.9 kg
- Housing: individually in PPO cages (floor area: 2576 cm²) with perforated floor
- Diet: Altromin 2123 (Altromin, Lage, Germany), ad libitum
- Water: domestic quality drinking water acidified with hydrochloric acid to pH 2.5, ad libitum
- Acclimation period: at least one week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 ± 3
- Humidity (%): 55 ± 15
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12 / 12 - Type of coverage:
- semiocclusive
- Preparation of test site:
- clipped
- Vehicle:
- other: ethanol/diethylphthalat 1:1
- Controls:
- yes, concurrent vehicle
- Amount / concentration applied:
- TEST MATERIAL
- Amount applied: 0.5 mL
- Concentration: 1, 10, 25, 50 and 100% - Duration of treatment / exposure:
- 4 h
- Observation period:
- 21 days
Reading time points: 1, 24, 48 and 72 h - Number of animals:
- 4
- Details on study design:
- TEST SITE
- Area of exposure: on the back (10 x 10 cm)
- Type of wrap: The test substance was applied to each of two 16-layer gauze patches (2.5 x 2.5 cm) and the patches were hold in place with adhesive Gothaplast tape (2.5 cm wide) and fixed with Gothaplast tape 85 cm width) loosely wound round the trunk.
REMOVAL OF TEST SUBSTANCE
- Washing: The treated skin was cleaned with mild soap and lukewarm water.
- Time after start of exposure: 4 h
OBSERVATION TIME POINTS
1, 24, 48 and 72 h and 7, 14 and 21 days
SCORING SYSTEM: Draize scoring system - Irritation parameter:
- erythema score
- Remarks:
- at 100%
- Basis:
- animal: #1, #2 and #3
- Time point:
- 24/48/72 h
- Score:
- 2
- Max. score:
- 4
- Reversibility:
- fully reversible within: 21 days
- Remarks:
- a slight redness and a slight formation of scales was observed in animal #1 after 21 days
- Irritation parameter:
- erythema score
- Remarks:
- at 100%
- Basis:
- animal #4
- Time point:
- 24/48/72 h
- Score:
- 1.7
- Max. score:
- 4
- Reversibility:
- fully reversible within: 21 days
- Irritation parameter:
- edema score
- Remarks:
- at 100%
- Basis:
- animal: #1 and #2
- Time point:
- 24/48/72 h
- Score:
- 0.7
- Max. score:
- 4
- Reversibility:
- fully reversible
- Irritation parameter:
- edema score
- Remarks:
- at 100%
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 1.7
- Max. score:
- 4
- Reversibility:
- fully reversible
- Irritation parameter:
- edema score
- Remarks:
- at 100%
- Basis:
- animal #3
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 4
- Reversibility:
- fully reversible
- Irritant / corrosive response data:
- 7 days after termination of exposure animal #1 showed thick, white scales distributed all over the anterior left (100%) and middle left (50%) test field. In animal #2, white scales distributed all over the anterior left test field (100%) as well as isolated, little white scales on the middle left test field were observed. Animal #3 showed thick, white scales distributed all over the anterior left test field (100%) as well as little, white scales on the middle left test field (50%). The posterior left (25%) and the right test fields (0, 1 and 10%) of animals #1, #2 and #3 were free of skin reactions. In animal #4, thick, white scales on the whole anterior left test field (100%), little white scales on the whole middle left test field (50%) as well as teeny-weeny scales on approximately 30% of the posterior left test area (25%) were observed. The right test fields (0, 1 and 10%) of this animal showed no skin reactions.
14 days after termination of exposure in animals #1 and #2 the scales were falled down on approximately 40% of the anterior left test area (100%). On the middle left test field (50%) intact skin was observed under the falled down scales crust. The posterior left (25%) and the right test fields (0, 1 an d10%) were free of any skin reactions. In animal #3, scales on approximately 30% of the anterior left test area (100%) were observed. The scale were falled down on the middle left test field (50%). Animal #4 showed white scales on approximately 50% of the anterior left test area (100%) as well as little, white scales on approximately 40% of the middle left test area (50%). The posterior left (25%) and the right test fields (0, 1 and 10%) of animals #3 and #4 were free of skin reactions.
21 days after termination of exposure animal #1 showed a slight redness and a slight formation of scales on the anterior left test field (100%). On the middle left test field (50%) few scales were observed. The posterior left (25%) and the right test fields (0, 1 and 10%) were free of skin reactions in this animal. Animals #2, #3 and #4 showed no signs of a skin reaction. - Interpretation of results:
- other: borderline result between no classification and Skin Cat. 2 (H315) according to Regulation (EC) No 1272/2008 for 100% test substance concentration.
- Conclusions:
- Under the conditions of this skin irritation study in rabbits scales were observed in all 4 test fields treated with 100% after 14 days. Slight scale formation was persistent in 1 animal (100%) until 21 days. Test substance concentrations of 1, 10, 25 and 50% were considered not irritating to the skin according to CLP criteria.
- Executive summary:
The skin irritation potential of the test substance was determined by an in vivo skin irritation test according to OECD Guideline 404 (adopted in 1992) and in compliance with GLP (2000). Test substance concentrations of 100, 50, 25, 10, 1 and 0% (vehicle only) were applied to the skin of 4 rabbits under semi-occlusive conditions for 4 hours. Scales were observed in all 4 test fields treated with 100% after 14 days. Slight scale formation persisted in 1 animal on the test field treated with 100% until 21 days. Since scales were still evident at the end of the observation period for the 100% test subtsance concentration, this result is considered borderline between no classification and skin irritation. Test substance concentrations of 1, 10, 25 and 50% were not irritating to the skin.
Referenceopen allclose all
Table 2. Results after treatment with the test substance and controls
Test group |
Mean absorbance at 570 nm* |
Rel. absorbance (%)** |
SD (%) |
Rel. absorbance (% of negative control)*** |
||||
Tissue 1 |
Tissue 2 |
Tissue 3 |
Tissue 1 |
Tissue 2 |
Tissue 3 |
|||
Negative control |
1.892 |
1.821 |
1.717 |
104.5 |
100.6 |
94.8 |
4.9 |
100.0 |
Positive control |
0.051 |
0.053 |
0.046 |
2.8 |
2.9 |
2.5 |
7.6 |
2.8 |
Test substance |
1.838 |
1.821 |
1.936 |
101.6 |
100.6 |
107.0 |
3.3 |
103.0 |
* Mean of three replicate wells after blank correction (blank = 0.041)
** Relative absorbance per tissue (rounded values): 100 × (absorbance tissue) / (mean absorbance negative control)
*** Relative absorbance per treatment group (rounded values): 100 × (absorbance test substance/positive control) / (mean absorbance negative control)
Table 1. Results of the skin irritation study.
Rabbit no. |
Test concentration |
Erythema |
Individual mean values 24/48/72 h |
Edema |
Individual mean values 24/48/72 h |
|||||||
1 h |
24 h |
48 h |
72 h |
1 h |
24 h |
48 h |
72 h |
|||||
1 |
AL |
100% |
2 |
2 |
2 |
2* |
2.0 |
1 |
1 |
1 |
0 |
0.7 |
AR |
10% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
ML |
50% |
1 |
2 |
2 |
1* |
1.7 |
0 |
1 |
1 |
0 |
0.7 |
|
MR |
1% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
PL |
25% |
0 |
1 |
1 |
0 |
0.7 |
0 |
0 |
0 |
0 |
0 |
|
PR |
V% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
2 |
AL |
100% |
2 |
2 |
2 |
2* |
2.0 |
2 |
2 |
2 |
1 |
1.7 |
AR |
10% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
ML |
50% |
1 |
2 |
2 |
2* |
2.0 |
2 |
2 |
2 |
1 |
1.7 |
|
MR |
1% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
PL |
25% |
0 |
1 |
1 |
1 |
1.0 |
0 |
1 |
0 |
0 |
0.3 |
|
PR |
V% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
3 |
AL |
100% |
2 |
2 |
2 |
2* |
2.0 |
2 |
1 |
1 |
1* |
1.0 |
AR |
10% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
ML |
50% |
1 |
1 |
1 |
1* |
1.0 |
1 |
0 |
0 |
0 |
0 |
|
MR |
1% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
PL |
25% |
0 |
1 |
0 |
0 |
0.3 |
0 |
0 |
0 |
0 |
0 |
|
PR |
V% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
4 |
AL |
100% |
1 |
1 |
2 |
2* |
1.7 |
1 |
1 |
0 |
1* |
0.7 |
AR |
10% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
ML |
50% |
0 |
1 |
2 |
2* |
1.7 |
0 |
1 |
0 |
0 |
0.3 |
|
MR |
1% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
PL |
25% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
PR |
V% |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
AL: anterior left treatment site
AR: anterior right treatment site
ML: middle left treatment site
MR: middle right treatment site
PL: posterior left treatment site
PR: posterior right treatment site
V: Vehicle (1:1 ethanol/diethylphthalate)
*: patch area sharp demarcated
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 17 Jun 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- July 2013
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Hess. Ministerium für Umwelt, Klimaschutz, Landwirtschaft und Verbraucherschutz, Wiesbaden, Germany
- Species:
- cattle
- Strain:
- not specified
- Details on test animals or tissues and environmental conditions:
- SOURCE OF COLLECTED EYES
- Source: Schlachthof Aschaffenburg, 63739 Aschaffenburg, Germany
- Characteristics of donor animals: at least 9 month old
- Storage, temperature and transport conditions of ocular tissue: The isolated eyes were transported in Hank's Buffered Salt Solution (HBSS) at ambient temperature.
- Time interval prior to initiating testing: The corneae were isolated on the same day after delivery of the eyes and directly used in the BCOP test.
- Indication of any existing defects or lesions in ocular tissue samples: All eyes were carefully examined macroscopically for defects. Those presenting defects such as vascularization, pigmentation, opacity and scratches were discarded. - Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount applied: 0.75 mL
POSITIVE CONTROL
- Amount applied: 0.75 mL
NEGATIVE CONTROL
- Amount applied: 0.75 mL - Duration of treatment / exposure:
- 10 min at 32 ± 1 °C
- Duration of post- treatment incubation (in vitro):
- 2 h
- Number of animals or in vitro replicates:
- in triplicates for each treatment and control group
- Details on study design:
- SELECTION AND PREPARATION OF CORNEAS:
The cornea was carefully removed from the eye using scalpel and rounded scissors. A rim of about 2 mm of tissue (sclera) was left for stability and handling of the isolated cornea. Each cornea was mounted in a specially designed cornea holder.
QUALITY CHECK OF THE ISOLATED CORNEAS:
At the end of the equilibration period, the basal opacity was determined (t0). Each cornea with a value of the basal opacity >7 was discarded.
TREATMENT METHOD:
The cornea holder consists of anterior and posterior compartments, which interface with the epithelial and endothelial sides of the cornea, respectively. The endothelial side of the cornea was positioned against the sealing ring (O-ring) of the posterior part of the holder. The cornea was gently flattened over the O-ring but stretching was avoided. The anterior part of the holder was positioned on the top of the cornea and fixed in place with screws. Both compartments of the holder were filled with incubation medium. The posterior compartment was filled first to return the cornea to its natural convex position. After equilibration for about 1 hour, the anterior compartment received the test substance or the controls on the surface of the corneae. The corneae were incubated in a horizontal position at 32 ± 1 °C in the water-bath for 10 minutes.
NUMBER OF REPLICATES: 3 corneae per test group
REMOVAL OF TEST SUBSTANCE:
The test substance was rinsed off from the application side with saline.
- POST-EXPOSURE INCUBATION: 2 h in a vertical position
METHODS FOR MEASURED ENDPOINTS:
- Corneal opacity: Corneal opacity was determined by the amount of light transmission through the cornea via an opacitometer (OP_KiT opacitometer, Electro Design, France).
- Corneal permeability: The passage of sodium fluorescein dye was measured with the aid of a microplate reader (Versamax Molecular Devices) at 490 nm (OD490).
SCORING SYSTEM: In Vitro Irritancy Score (IVIS), IVIS = opacity value + (15x OD490 value)
DECISION CRITERIA:
Test substance with an IVIS > 55 was regarded as serious eye damage and labelled Category 1 according to CLP/EPS/GHS.
Test substance with an IVIS ≤ 3 was regarded as non-irritant and labelled in no category.
Test substance with an IVIS > 3; ≤ 55 no prediction can be made. - Irritation parameter:
- in vitro irritation score
- Run / experiment:
- mean value of 3 corneae
- Value:
- 0.29
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- With the negative control (0.9% (w/v) NaCl solution in deionised water) neither an increase of opacity nor permeability of the corneae could be observed.
The positive control (2-ethoxyethanol) showed clear opacity and distinctive permeability of the corneae (mean IVIS = 83.03) corresponding to a classification as serious eye damaging.
Relative to the negative control, the test substance did neither cause an increase of the corneal opacity nor permeability (mean IVIS = 0.29).
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: The negative control resulted in opacity and permeability values that were less than the established upper limits for background opacity and permeability values for bovine corneae treated with the respective negative control.
- Acceptance criteria met for postive control: The positive control resulted in an IVIS which was within two standard deviations of the current historical mean. - Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008
- Conclusions:
- Under the conditions of the BCOP assay the test substance was not irritating to the eye. Application of the test substance to bovine corneae resulted in a calculated mean IVIS of 0.29.
- Executive summary:
The eye irritation/corrosion potential of the test substance was determined by a bovine corneal opacity and permeability (BCOP) test according to OECD Guideline 437 and in compliance with GLP (2016). Application of the test substance to bovine corneae resulted in a calculated mean IVIS of 0.29 and thus the test substance was not considered as irritating to the eye.
Reference
Table 2. Results after 10 min incubation time.
Test group |
Opacity value = |
Permeability at 490 nm (OD490) |
IVIS |
Mean IVIS |
||
|
Mean |
|
Mean |
|
|
|
Negative control |
0 |
0 |
0.062 |
0.066 |
0.93 |
0.99 |
0 |
0.058 |
0.87 |
||||
0 |
0.078 |
1.17 |
||||
Positive control |
51* |
1.268* |
70.02 |
83.03 |
||
57* |
1.821* |
84.32 |
||||
72* |
1.517* |
94.76 |
||||
Test substance |
1* |
-0.006* |
0.91 |
0.29 |
||
1* |
-0.006* |
0.91 |
||||
-1* |
0.003* |
-0.96 |
*: corrected values
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Skin
The skin irritation potential of the test substance was determined by an in vivo skin irritation test according to OECD Guideline 404 (adopted in 1992) and in compliance with GLP (2000). Test substance concentrations of 100, 50, 25, 10, 1 and 0% (vehicle only) were applied to the skin of 4 rabbits under semi-occlusive conditions for 4 hours. Scales were observed in all 4 test fields treated with 100% after 14 days. Slight scale formation persisted in 1 animal on the test field treated with 100% until 21 days. Since scales were still evident at the end of the observation period for the 100% test subtsance concentration, this result is considered borderline between no classification and skin irritation. Test substance concentrations of 1, 10, 25 and 50% were not irritating to the skin.
One further study was considered for the evaluation of the endpoint skin irritation/corrosion.
The skin irritation potential of the test substance was determined by an in vitro skin irritation test using a human skin model according to OECD Guideline 439 and in compliance with GLP (2016). After treatment with 30 µL of the test substance the mean relative absorbance value was 103.0% compared to the negative control (threshold for classification <50%).
Based on a weight of evidence taking into account the available data described above, the test substance is not considered as skin irritant and thus not classified for skin irritation/corrosion according to Regulation (EC) No 1272/2008.
Eye
The eye irritation/corrosion potential of the test substance was determined by a bovine corneal opacity and permeability (BCOP) test according to OECD Guideline 437 and in compliance with GLP (2016). Application of the test substance to bovine corneae resulted in a calculated mean IVIS of 0.29 and thus the test substance was not considered as irritating to the eye.
Justification for classification or non-classification
The available data on skin and eye irritation do not meet the criteria for classification according to Regulation (EC) 1272/2008, and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
